Cargando…
The mechanisms of delayed onset type adverse reactions to oseltamivir
Oseltamivir is recommended for the treatment and prophylaxis of influenza in persons at higher risk for influenza complications such as individuals with diabetes, neuropsychiatric illnesses, and respiratory, cardiac, renal, hepatic or haematological diseases. However, a recent Cochrane review report...
Autor principal: | Hama, Rokuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973146/ https://www.ncbi.nlm.nih.gov/pubmed/27251370 http://dx.doi.org/10.1080/23744235.2016.1189592 |
Ejemplares similares
-
The mechanisms of sudden‐onset type adverse reactions to oseltamivir
por: Hama, R., et al.
Publicado: (2016) -
Adverse drug reaction profile of oseltamivir in children
por: Dalvi, Prashant S., et al.
Publicado: (2011) -
Adverse drug reaction of oseltamivir in pediatric patients
por: Wiwanitkit, Somsri, et al.
Publicado: (2012) -
Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports
por: Jefferson, Tom, et al.
Publicado: (2014) -
Severe and delayed-onset acneiform eruptions as an adverse reaction to regorafenib
por: Otsuka, Haruhiko, et al.
Publicado: (2022)